Lourdes Farre
L'hospitalet De Llobregat, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Modeling of ex vivo immune response reveals a central role for CD8+CD25+ cells in Adult T-cell Leukemia survival: a long-term prospective cohort study.
Journal: Tumour virus research
Published: January 31, 2026
Specific targeting of the pseudogene RPSAP52 reduces ovarian tumor growth in patient-derived orthoxenograft models.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 22, 2025
Infective dermatitis associated with human T-cell lymphotropic virus type-1, an underdiagnosed disease.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: February 06, 2024
The importance of the clinical classification of adult T-cell leukemia/lymphoma (ATLL) in the prognosis.
Journal: PLoS neglected tropical diseases
Published: March 07, 2022
Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases.
Journal: Molecular cancer
Published: March 16, 2021
Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studies.
Journal: Disease models & mechanisms
Published: December 07, 2020
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade.
Journal: Nature communications
Published: October 30, 2020
XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis.
Journal: Blood cancer journal
Published: September 01, 2020
Use of patient derived orthotopic xenograft models for real-time therapy guidance in a pediatric sporadic malignant peripheral nerve sheath tumor.
Journal: Therapeutic advances in medical oncology
Published: November 28, 2019
Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours.
Journal: Nature communications
Published: October 28, 2019
Last Updated: 09/26/2026